Anti-cldn18.2 antibody and use thereof
US-2024409629-A1 · Dec 12, 2024 · US
This page is not indexed by search engines while we improve data quality.
Chia Tai Tianqing Pharmaceutical Group Co Ltd patents in 2024
Chia Tai Tianqing Pharmaceutical Group Co Ltd was listed as an assignee on 41 patent publications in 2024.
| Metric | Value |
|---|---|
| Company | Chia Tai Tianqing Pharmaceutical Group Co Ltd |
| Year | 2024 |
| Patents | 41 |
Patents
Representative publications for Chia Tai Tianqing Pharmaceutical Group Co Ltd in 2024.
Pyrrolopyrazole spiro compound
US-2024409543-A1 · Dec 12, 2024 · US
Pyrimidine tricyclic derivative and pharmaceutical application thereof
US-2024409560-A1 · Dec 12, 2024 · US
Use of anti-cd40 antibody
US-2024398942-A1 · Dec 5, 2024 · US
Pharmaceutical composition of humanized monoclonal anti-PD-L1 antibody
US-12150990-B2 · Nov 26, 2024 · US
Top CPC classifications
Most common classification codes for Chia Tai Tianqing Pharmaceutical Group Co Ltd in 2024.
| CPC | Patents |
|---|---|
| A61P35/00 | 28 |
| A61K2039/505 | 14 |
| C07K2317/24 | 12 |
| A61K31/519 | 10 |
| C07D471/04 | 10 |
Related pages
Navigate to parent entity pages.